期刊文献+

^(18)F-FDGPET/CT显像在甲状腺病变的应用:与病理对比分析 被引量:7

Application of ^(18)F-FDG PET/CT in thyroid disease and correlative with histopathological results
下载PDF
导出
摘要 目的:探讨18F-FDG PET/CT在甲状腺病变中的应用意义。方法:回顾性分析经病理明确诊断的28例甲状腺病变的18F-FDG PET/CT影像学资料,男13例,女15例,年龄25~84岁,术后病理26例,穿刺病理2例,其中10例患者甲状腺有2个或多个病变,共包括8个恶性病变、31个良性病变。结果:8个恶性病变中7个甲状腺癌均表现为局灶性FDG代谢增高,1个淋巴瘤累及甲状腺病灶表现为弥漫性FDG代谢增高;31个良性病变中5个PET和CT均未显示,17个PET显示阴性、CT显示形态学改变,9个PET和CT均显示阳性改变;9个FDG代谢高摄取的良性病变包括2个结节性甲状腺肿、2个滤泡性腺瘤、2个慢性淋巴细胞性甲状腺炎、1个腺瘤样增生、1个甲状腺慢性炎症、1个亚急性甲状腺炎;甲状腺癌SUVmax与病灶最大径不相关(P=0.069)、与病灶平均密度也不相关(P=0.495);FDG高代谢摄取的8个恶性病变和9个良性病变其SUVmax无统计学差异(P=0.134);8个恶性病灶、31个良性病灶其钙化发生率无统计学差异(P=0.088),但沙粒样钙化的发生率却有显著统计学差异(P=0.038)。结论:18F-FDG PET/CT单纯依靠SUV值不能鉴别甲状腺良、恶性病变,CT显示沙粒样钙化对甲状腺癌具有高度提示价值;FDG阴性摄取及FDG弥漫性摄取的甲状腺病变为良性可能性大,甲状腺局灶性FDG摄取灶为恶性病变的概率较大,前两者需建议超声随访,而后者需建议超声引导下抽吸活检。 Objective: To explore the value of 18F-FDG PET/CT in the diagnosis of thyroid disease. Methods: Twentyeight patients (13 male and 15 female, aged ranged from 25 to 84 years old) with pathological diagnosis of thyroid disease were retrospectively analyzed on 18F-FDG PET/CT. Surgical operation (26 cases) and fine-needle aspiration (2 cases) were performed on these patients, of whom 10 patients had more than one lesion in thyroid gland. Therefore, 8 malignant thyroid lesions and 31 benign thyroid lesions were included in the study. Results: Focal uptake and diffuse uptake were respectively shown in 7 thyroid cancer and 1 thyroid lymphoma. Of 31 benign thyroid lesions, both PET and CT were negative in 5, both PET and CT were positive in 9, PET was negative and CT was positive in 17. Nine benign thyroid lesions with increased FDG uptake comprised nodular goiter, follicular adenoma, Hashimoto's thyroiditis, adenomatoid hyperplasia, chronic thyroiditis and subacute thyroiditis. The SUVmax was not correlated with maximum length and average density in thyroid cancer. There was no statistically significant difference on SUVmax between 8 malignant thyroid lesions and 9 benign thyroid lesions with high FDG uptake. The calcification did not show statistically significant difference between 8 malignant thyroid lesions and 31 benign thyroid lesions, but the sand-like calcification showed so. Conclusions: When PET/CT is used to evaluate the thyroid disease, only with SUV value can not discriminate malignant lesions from benign lesions and the sand-like calcification seen on CT may aid to identify thyroid cancer. The lesions with no FDG uptake and diffuse FDG uptake in thyroid gland are beign to a great extent, but the lesion with focal uptake in it is likely malignant. The former two are suggestive of follow-up with ultrasound, the latter is suggestive of fine-needle aspiration by ultrasound guidance.
出处 《中国临床医学影像杂志》 CAS 2013年第4期242-246,263,共6页 Journal of China Clinic Medical Imaging
基金 江苏省自然科学基金(编号:BK2011665) 南京军区南京总医院立项课题(编号:2011024)
关键词 甲状腺疾病 正电子发射断层显像术 氟脱氧葡萄糖F18 Thyroid diseases Positron-emission tomography Fluorodeoxyglucose F18
  • 相关文献

参考文献20

  • 1Mitchell JC, Grant F, Evenson AR, et al. Preoperative evaluation of thyroid nodules with SFDG-PET/CT [J]. Surgery, 2005, 138(6): 1166-1175.
  • 2Chen W, Parsons M, Torigian DA, et al. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging[J]. Nuel Med Commun, 2009, 30(3): 240-244.
  • 3Bae JS, Chae BJ, Park WC, et al. Incidental thyroid lesions de- tected by FDG-PET/CT: prevalence and risk of thyroid cancer[J]. World J Surg Oncol, 2009, 7: 63.
  • 4Nishimori H, Tabah R, Hickeson M, et al. Incidental thyroid "PETomas": clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake[J]. Can J Surg, 2011, 54(2): 83-88.
  • 5Pagano L, Sama MT, Morani F, et al. Thyroid incidentaloma i- dentified by 8F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance[J]. Clin Endocrinol, 2011, 75(4): 528-534.
  • 6翟歌,李彪,张淼,张敏,徐昊平,江旭峰,王超,弋贵芝,孙成伟,朱承谟.18^F-FDG PET/CT全身显像对甲状腺偶发瘤的临床意义[J].中华核医学杂志,2009,29(2):78-81. 被引量:12
  • 7关志伟,徐白萱,陈英茂,张锦明,田嘉禾.大规模人群FDG PET/CT意外发现甲状腺高代谢结节的回顾性分析[J].中华核医学与分子影像杂志,2012,32(1):32-35. 被引量:27
  • 8Choi JY, Lee KS, Kim HJ, et al. Focal thyroid lesions inciden- tally identified by integrated ISF-FDG PET/CT: clinical signifi- cance and improved characterization[J]. J Nucl Med, 2006, 47(4): 609-615.
  • 9Chu QD, Connor MS, Lilien DL, et al. Positron emission tomog- raphy(PET) positive thyroid incidentaloma: the risk of malignancy observed in a tertiary referral center [J]. Am Surg, 2006, 72(3): 272-275.
  • 10Wong C, Lin M, Chicco A, et al. The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography(PET/CT) in patients with non-thyroidal malignancy[J]. Acta Radiol, 2011, 52(8): 899-904.

二级参考文献31

  • 1Burguera B, Gharib H. Thyroid incidentalomas : prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am, 2000, 29: 187-203.
  • 2Dario Ramos C, Chisin R, Yeung HW, et al. Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumor. Clin Nucl Med, 2001,26: 193-197.
  • 3Chen YK, Ding HJ, Chen KT, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18 F-fluorodeoxyglucosepositron emission tomography for cancer screening in healthy subjects. Anticancer Res, 2005, 25 : 1421-1426.
  • 4Kang KW, Kim SK, Kang HS, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fiuorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab, 2003, 88 : 4100-4104.
  • 5Kim TY, Kim WB. is F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope, 2005, 115: 1074-1078.
  • 6Choi JY, Lee KS, Kwon OJ, et al. Improved detection of second primary cancer using integrated lSF-fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Chn Oncol, 2005, 23: 7654-7659.
  • 7Rheingold SR, Neugut AI, Meadows AT. Secondary cancers : incidence, risk factors, and management//Kufe DW, Pollock RE, Weichselbaum RR, et al. Cancer Medicine. 6th ed. Hamilton: BC Decker, 2003: 2623-2631.
  • 8Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York : Springer-Verlag, 2002 : 77-84.
  • 9de Geus-Oei LF, Pieters GFFM, Bonenkamp JJ, et al. ISF-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results. J Nucl Med, 2006, 47: 770-775.
  • 10Nakamoto Y,Tatsumi M. Normal FDG distribution pattems in the head and neck : PET/CT evaluation. Radiology, 2005,234:879 -885.

共引文献33

同被引文献75

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部